Toral Parikh
Reproductive Endocrinology · Houston, TXNPI 1891053583
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 100 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $959 and has fallen 91.0% since, to $87 in 2025.
Across 100 payments — averaging $22.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$430
- Organon$233
- Ferring Pharmaceuticals Inc.$206
- Minerva Surgical, Inc$138
- Coopersurgical, Inc.$127
- E.r. Squibb & Sons, L.L.C.$123
- plus $1K from 22 others
What the payments were for
- Food & beverage$2,298100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 23 | $430 |
| Organon | 10 | $233 |
| Ferring Pharmaceuticals Inc. | 6 | $206 |
| Minerva Surgical, Inc | 2 | $138 |
| Coopersurgical, Inc. | 7 | $127 |
| E.r. Squibb & Sons, L.L.C. | 1 | $123 |
| Evofem Biosciences, Inc. | 9 | $112 |
| Exeltis, USA Inc. | 7 | $100 |
| Avion Pharmaceuticals | 7 | $99 |
| Boston Scientific | 1 | $99 |
| Gilead | 1 | $96 |
| Myovant Sciences Inc. | 4 | $86 |
| Lupin Inc. | 3 | $57 |
| Johnson & Johnson | 1 | $50 |
| Acadia Pharmaceuticals Inc | 1 | $42 |
| Therapeuticsmd, Inc. | 2 | $39 |
| Sage Therapeutics, LLC | 2 | $32 |
| Mayne Pharma Commercial LLC | 2 | $32 |
| Agile Therapeutics, Inc. | 2 | $27 |
| Galen US Inc | 1 | $24 |
| Merck | 1 | $23 |
| Meditrina | 1 | $22 |
| Irhythm Technologies, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
| GSK | 1 | $18 |
| Mission Pharmacal Company | 1 | $15 |
| Mylan Pharmaceuticals Inc. | 1 | $14 |
| Bayer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,298 in reported general payments places this provider in the 70th percentile of 142 reproductive endocrinology providers in Texas.
Other reproductive endocrinology in Houston
- Randall DunnHouston$234K
- Craig WitzHouston$32K
- Jason YehHouston$31K
- Katherine McKnightHouston$13K
- James NodlerHouston$11K
- Ghassan HaddadHouston$7K
- Nischelle KalakotaHouston$3K
- Guillermo RoweHouston$3K
- George GrunertHouston$3K
- Timothy DunnHouston$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.